Literature DB >> 30619787

Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease.

Matthias Torsten1, Lerner Aaron1,2.   

Abstract

The enzyme microbial transglutaminase is heavily used in the food processing industries to ameliorate food qualities and elongate the products' shelf life. As a protein's glue, it cross-links gliadin peptides, creating neo-complexes that are immunogenic and potentially pathogenic to celiac disease communities. Even lacking sequence identity, it imitates functionally the endogenous tissue transglutaminase, known to be the autoantigen of celiac disease and representing an undisputable key player in celiac disease initiation and progress. The present review expend on the enzyme characteristics, exogenous intestinal sources, its cross-linking avidity to gluten or gliadin, turning naïve protein to immunogenic ones. Several observation on microbial transglutaminase cross linked complexes immunogenicity in celiac patients are reviewed and its pathogenicity is summarized. Warnings on its potential risks for the gluten dependent conditions are highlighted. When substantiated, it might represent a new environmental factor of celiac disease genesis. It is hoped that the presented knowledge will encourage further research to explore the mechanism and the pathogenic pathways taken by the gliadin cross linked enzyme in driving celiac disease.

Entities:  

Keywords:  celiac disease; cross linking; food additive; gluten; microbial transglutaminase; microbiome

Year:  2018        PMID: 30619787      PMCID: PMC6297833          DOI: 10.3389/fped.2018.00389

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  9 in total

1.  Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.

Authors:  D Agardh; T Matthias; P Wusterhausen; S Neidhöfer; A Heller; A Lerner
Journal:  Clin Exp Immunol       Date:  2019-11-11       Impact factor: 4.330

2.  Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy.

Authors:  Ahmed Dawood Mohammed; Md A Wadud Khan; Ioulia Chatzistamou; Douja Chamseddine; Katie Williams-Kang; Mason Perry; Reilly Enos; Angela Murphy; Gregorio Gomez; Ahmed Aladhami; Carole A Oskeritzian; Amy Jolly; Yan Chang; Shuqian He; Zui Pan; Jason L Kubinak
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

Review 3.  Navigating the Gluten-Free Boom: The Dark Side of Gluten Free Diet.

Authors:  Aaron Lerner; Thomas O'Bryan; Torsten Matthias
Journal:  Front Pediatr       Date:  2019-10-15       Impact factor: 3.418

4.  Defective humoral immunity disrupts bile acid homeostasis which promotes inflammatory disease of the small bowel.

Authors:  Ahmed Dawood Mohammed; Zahraa Mohammed; Mary M Roland; Ioulia Chatzistamou; Amy Jolly; Lillian M Schoettmer; Mireya Arroyo; Khadija Kakar; Yuan Tian; Andrew Patterson; Mitzi Nagarkatti; Prakash Nagarkatti; Jason L Kubinak
Journal:  Nat Commun       Date:  2022-01-26       Impact factor: 17.694

5.  Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.

Authors:  Aaron Lerner; Polina Sobolevskaia; Leonid Churilov; Yehuda Shoenfeld
Journal:  J Transl Autoimmun       Date:  2021-06-16

6.  Microbial transglutaminase should be considered as an environmental inducer of celiac disease.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

Review 7.  Processed Food Additive Microbial Transglutaminase and Its Cross-Linked Gliadin Complexes Are Potential Public Health Concerns in Celiac Disease.

Authors:  Aaron Lerner; Torsten Matthias
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

Review 8.  "Let Food Be Thy Medicine": Gluten and Potential Role in Neurodegeneration.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

9.  Gluten-free diet exposure prohibits pathobiont expansion and gluten sensitive enteropathy in B cell deficient JH-/- mice.

Authors:  Ahmed Dawood Mohammed; Nia Hall; Ioulia Chatzistamou; Amy Jolly; Jason Lee Kubinak
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.